MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction

@inproceedings{MhawechFauceglia2012METHGFSP,
  title={MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction},
  author={Paulette Mhawech-Fauceglia and Michelle Afkhami and Tanja Pejovi{\'c}},
  booktitle={Pathology research international},
  year={2012}
}
The HGF/MET signaling pathway is abnormal in numerous cancers including ovarian cancer. MET is expressed in 70% of human cancer and it is overexpressed in 30% of ovarian cases and cancer cell lines. The HGF/MET pathway plays a role in the initiation and progression of ovarian cancer through the most distinctive biologic program known as "invasive growth" which is accomplished through a coordinated activation of cell motility, invasiveness, degradation of extracellular matrix, survival, and… CONTINUE READING
Highly Cited
This paper has 66 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.
7 Citations
65 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

67 Citations

02040'13'14'15'16'17'18
Citations per Year
Semantic Scholar estimates that this publication has 67 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 65 references

Similar Papers

Loading similar papers…